Michael E. Hart
Directeur/Membre du Conseil chez Affygility Solutions
Provenance du réseau au premier degré de Michael E. Hart
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
Affygility Solutions
 Affygility Solutions Miscellaneous Commercial ServicesCommercial Services Affygility Solutions is a private company that provides occupational health, safety, and toxicology services to the life science industry. The company is based in Broomfield, CO and was founded in 2002. The company's services include the Affytrac EH&S management tool, potent compound safety and categorization, occupational exposure limits, and acceptable daily exposure limits for active pharmaceutical ingredients, and genotoxic impurity evaluations. The company has provided these services to small, mid-size, and large life science companies in over 65 different countries. The CEO is Dean Calhoun.
3
| Private Company | Miscellaneous Commercial Services | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Michael E. Hart via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| The University of Colorado | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree | |
| INTERMUNE INC | Biotechnology | Director of Finance/CFO Director/Board Member | |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Investment Committee Member Private Equity Investor | |
Alita Pharmaceuticals, Inc.
 Alita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alita Pharmaceuticals, Inc. develops, manufactures and distributes urologic and female healthcare products. It offers product testing, research and development services. The company was founded by Carole S. Ben-Maimon and Warburg Pincus in September 2006 and is headquartered in Radnor, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| WUXI XDC CAYMAN INC. | Miscellaneous Commercial Services | Director/Board Member | |
| XENOPORT, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Wisconsin | College/University | Undergraduate Degree | |
| University of Kentucky | College/University | Undergraduate Degree | |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Pharmaceuticals: Major | Director/Board Member | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
BASF SA
 BASF SA Chemicals: Major DiversifiedProcess Industries Part of BASF SE, BASF SA is a Brazilian company that manufactures chemicals, paints, agricultural products and others. The company is based in São Paulo, Brazil. | Chemicals: Major Diversified | Sales & Marketing | |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Pharmaceuticals: Major | Sales & Marketing | |
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Pharmaceuticals: Major | Director/Board Member | |
The Jackson Laboratory
 The Jackson Laboratory BiotechnologyHealth Technology The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME. | Biotechnology | Director/Board Member | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer | |
| ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MELINTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| LARIMAR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Deerfield Management Co. LP (Private Equity)
 Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Investment Managers | Private Equity Investor | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Medical/Nursing Services | Director/Board Member | |
Adaptive Phage Therapeutics, Inc.
 Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Adaptive Phage Therapeutics, Inc. provides therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. The company was founded by Gregory L. Merril and Carl R. Merril and is headquartered in Bethesda, MD. | Miscellaneous Commercial Services | Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree | |
| Columbia University Medical Center | College/University | Director/Board Member | |
Serrado Capital LLC
 Serrado Capital LLC Investment ManagersFinance Serrado Capital LLC is an independent hedge fund manager headquartered in Brookline, Massachusetts. The firm was founded by Stewart Hen in 2010. Serrado Capital provides investment advice to high net worth clients. | Investment Managers | Chief Executive Officer | |
| BIOMX INC. | Biotechnology | Director/Board Member | |
| University of Pennsylvania | College/University | Masters Business Admin | |
| University of Delaware | College/University | Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | Director/Board Member | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
| CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman | |
| Metropolitan State University of Denver | College/University | Undergraduate Degree | |
| MIT Sloan School of Management | College/University | Masters Business Admin | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Honeywell Corp. | Corporate Officer/Principal | ||
| Syntex Chemicals, Inc. | Human Resources Officer |
Statistiques
Internationale
| Etats-Unis | 44 |
| Chine | 3 |
| Brésil | 2 |
| Allemagne | 2 |
| Israël | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 12 |
| Finance | 5 |
| Commercial Services | 4 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 84 |
| Independent Dir/Board Member | 23 |
| Corporate Officer/Principal | 17 |
| President | 13 |
| Chairman | 11 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jonathan Leff | 45 |
| Paul Berns | 28 |
| Timothy Patrick Lynch | 16 |
| Stewart John Hen | 15 |
| Michael D. Casey | 14 |
| Jeremy Bender | 12 |
| Barbara E. Baring | 8 |
| David Clark | 7 |
| Marc H. Graboyes | 6 |
| David A. DeLong | 2 |
| Michael E. Saunders | 2 |
| Donald J. Abraham | 1 |
| Dean Calhoun | 1 |
| Christopher Tompkins | 1 |
| Jill Loureiro | 1 |
- Bourse
- Insiders
- Michael E. Hart
- Connexions Sociétés
